Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024

The Prognostic Value of Del(1p32) in Patients with Newly Diagnosed Multiple Myeloma.

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRui GuoXSXuxing ShenYXYuan Xia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guo et al. (2024) studied this question.

synapsesocial.com/papers/68e66dd2b6db6435875f9214https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.03.017
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone2025 · 3 citations
  2. 2Real-world poor prognostic impact of del(1p32) in newly diagnosed multiple myeloma among Asian populations2025
  3. 3P21 | THE LONG TERM PROGNOSTIC IMPACT OF CHROMOSOME 1 ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS2026
  4. 41p and 1q: Partners in crime in multiple myeloma.2024
  5. 5Outcomes of de novo del(17p) in multiple myeloma.2026